The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TROPION-Lung14: A phase 3 study of osimertinib ± datopotamab deruxtecan (Dato-DXd) as first-line (1L) treatment for patients with EGFR-mutated locally advanced or metastatic (LA/M) non-small cell lung cancer (NSCLC).
 
Shun Lu
Leadership - Innovent BIOLOGICS, INC; Shanghai Fosun; Simcere Zaiming
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; InventisBio Co. Ltd; Menarini; Pfizer; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh Pharma; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Hansoh (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly Suzhou Pharmaceutical Co. (Inst); Roche (Inst)
 
Mariano Provencio
Honoraria - AstraZeneca; BMS; Janssen; Lilly; MSD; Pfizer; Roche; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; Guardant Health; Incyte; Ipsen; Janssen Oncology; Johnson & Johnson; Lilly; Merck; MSD; Pfizer; Roche; Roche; Takeda
Speakers' Bureau - Amgen; AstraZeneca; BMS; Janssen; Johnson & Johnson/Janssen; Lilly; MSD; Pfizer; Roche; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; BMS; Boehringer Ingelheim; Boehringer Ingelheim; Bristol Myers Squibb Company; Janssen; Lilly; MSD; Pfizer; Pierre Fabre; Roche; Roche; ROCHE; Takeda
Other Relationship - Pfizer
 
Aaron Lisberg
Employment - Boston Scientific (I)
Stock and Other Ownership Interests - Boston Scientific (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo Nordics; G1 Therapeutics; Gilead Sciences; IQVIA; Janssen Oncology; Jazz Pharmaceuticals; Leica Biosystems; Lilly; Molecular Axiom; MorphoSys; Novartis; Novocure; Oncocyte; Pfizer; Sanofi; Sanofi/Regeneron
Research Funding - AstraZeneca; Calithera Biosciences; Daiichi Sankyo; Dracen; Duality Biologics; eFFECTOR Therapeutics; WindMIL
Patents, Royalties, Other Intellectual Property - Pending Patents U.S. Provisional Patent Application No. 63/527,899
 
Eldsamira Mascarenhas
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; Pfizer; Roche
Travel, Accommodations, Expenses - Daichii; Janssen Oncology; Roche
 
Junko Tanizaki
Honoraria - AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb Co. Ltd.; Chugai Pharma; Daiichi sankyo Co., Ltd.; EMD Serono/Merck; Janssen; Lilly Japan; MSD; Nihon Medi-Physics; Nippon Kayaku; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; DAIICHI SANKYO COMPANY, LIMITED
Speakers' Bureau - Abbvie; AstraZeneca Japan
 
Ying Cheng
No Relationships to Disclose
 
Hye Ryun Kim
Honoraria - AstraZeneca; MSD Oncology
Consulting or Advisory Role - AstraZeneca; BeiGene
Speakers' Bureau - ABL Bio; AstraZeneca; MSD Oncology; Ono Pharmaceutical; Roche/Genentech; Yuhan
Research Funding - AstraZeneca (Inst); Yuhan (Inst)
 
Yinglei Liu
Employment - AstraZeneca
 
Shengmei Feng
Employment - AstraZeneca
 
Lishi Zhang
Employment - AstraZeneca
 
Laurence Toms
Employment - AstraZeneca
 
James Chih-Hsin Yang
Honoraria - Amgen (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo/Astra Zeneca (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Amgen (Inst); ArriVent Biopharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Janssen Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); MSD Oncology (Inst); Takeda (Inst)
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Dizal Pharma; Takeda
 
Sarah Goldberg
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Daiichi Sankyo; Janssen; Lilly; Merck; Regeneron; Summit Therapeutics; Synthekine
Research Funding - Adela; Agenus (Inst); Amgen (Inst); AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Genentech (Inst); Merck (Inst); Mirati Therapeutics; ORIC Pharmaceuticals (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst); Vitrak (Inst)